SC 13D

SCHEDULE 13D

Company: NovoCure Ltd
Filed: March 9, 2017
Accession Number: 0001123292-17-000595

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →

View Document ↗ View on SEC.gov ↗